# Sun‐Hong Kwon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sun-hong-kwon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 439 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 13 |
| i10-index | 14 |
| Last Known Institution | Sungkyunkwan University |
| OpenAlex ID | https://openalex.org/A5002867428 |
| ORCID iD | 0000-0002-1058-8392 |
| Works | 61 |

## Researcher papers

- [Visual Outcomes and Optical Quality of Accommodative, Multifocal, Extended Depth-of-Focus, and Monofocal Intraocular Lenses in Presbyopia-Correcting Cataract Surgery](https://scholariq.org/papers/visual-outcomes-and-optical-quality-of-accommodative-multifocal-extended-depth/)
- [Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database](https://scholariq.org/papers/health-care-utilization-and-direct-costs-in-mild-moderate-and-severe-adult/)
- [Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach](https://scholariq.org/papers/comparative-effectiveness-of-cycling-of-tumor-necrosis-factor-tnf-inhibitors/)
- [Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer](https://scholariq.org/papers/concomitant-use-of-proton-pump-inhibitors-and-palbociclib-among-patients-with/)
- [Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea](https://scholariq.org/papers/eliciting-societal-preferences-of-reimbursement-decision-criteria-for-anti/)
- [Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis](https://scholariq.org/papers/clinical-manifestation-economic-burden-and-mortality-in-patients-with/)
- [Cost‐effectiveness study of <scp>FIB</scp>‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a <scp>NAFLD</scp> at‐risk population](https://scholariq.org/papers/cost-effectiveness-study-of-scp-fib-scp-4-followed-by-transient-elastography/)
- [A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments](https://scholariq.org/papers/a-systematic-review-of-economic-evaluations-of-active-tuberculosis-treatments/)
- [Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis](https://scholariq.org/papers/lipid-profile-changes-induced-by-glucagon-like-peptide-1-receptor-agonists-in/)
- [Optimal Indicator of Death for Using Real-World Cancer Patients' Data From the Healthcare System](https://scholariq.org/papers/optimal-indicator-of-death-for-using-real-world-cancer-patients-data-from-the/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Researcher university

- [Sungkyunkwan University](https://scholariq.org/institutions/sungkyunkwan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.